Cargando…
Acute Fulminant Hepatic Failure and Renal Failure Induced by Oral Amiodarone: A Case Report and Literature Review
Amiodarone is a class III antiarrhythmic agent that inhibits adrenergic stimulation by blocking alpha and beta receptors. It prolongs action potential and refractory period in myocardial tissue. Its remarkably long half-life is associated with a myriad of adverse events. Here, we present an 85-year-...
Autores principales: | Campbell, Natasha, Agarwal, Khushboo, Alidoost, Marjan, Miskoff, Jeffrey A, Hossain, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255555/ https://www.ncbi.nlm.nih.gov/pubmed/32489749 http://dx.doi.org/10.7759/cureus.8311 |
Ejemplares similares
-
Proarrhythmia in a Patient With Heart Failure on Therapy With Amiodarone
por: Semerdzhieva, Niya E, et al.
Publicado: (2021) -
Concomitant Acute Hepatic Failure and Renal Failure Induced by Intravenous Amiodarone: A Case Report and Literature Review
por: Mohamed, Mujtaba, et al.
Publicado: (2020) -
Prolonged Jaundice Secondary to Amiodarone Use: A Case Report and Literature Review
por: Bratton, Hunter, et al.
Publicado: (2019) -
A Case of Isolated SARS-CoV-2 Fulminant Myopericarditis Without Respiratory Failure
por: Afriyie, Felix, et al.
Publicado: (2021) -
When a Cure Becomes a Curse: The Complex Clinical Scenario Involving Amiodarone Therapy and BRASH (Bradycardia, Renal failure, Atrioventricular Nodal Blockade, Shock, and Hyperkalemia) Syndrome
por: Phuyal, Prabin, et al.
Publicado: (2023)